Ascendis Pharma A/S Profit Margin

Ascendis Pharma A/S's profit margin stands at 58.4% as of March 2026. That compares with -92.77% in the prior-year period — up 162.9% year over year. That is above the Healthcare sector average of 15.58%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Ascendis Pharma A/S reported 58.4% in profit margin versus -92.77% a year earlier — a 162.9% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

Ascendis Pharma A/S sits higher the Healthcare benchmark (15.58%) with a profit margin of 58.4%. That is roughly 274.7% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of 58.4% for Ascendis Pharma A/S means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Ascendis Pharma A/S's profit margin evolved across reporting periods, while the comparison chart places ASND next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.